Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

50

Revenue 2017

Levemir

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Levemir was produced by Novo Nordisk.

Lilly and Boehringer launch first Lantus clone Basaglar in US

Lilly and Boehringer launch first Lantus clone Basaglar in US Nordisk's Levemir (insulin detemir) and Tresiba (insulin degludec). ... The list price of Basaglar in the US is $316.85 for a pack of five autoinjector pens, which also undercuts Sanofi's Lantus follow-up Toujeo, as well as Levemir

Sanofi fires off another lawsuit against a Lantus biosimilar

Sanofi fires off another lawsuit against a Lantus biosimilar Lantus made more than $7bn in sales last year but is already showing the effects of competition from biosimilars and other branded basal insulin rivals such as Novo Nordisk's Levemir

Lilly and Boehringer launch Lantus biosimilar in UK

Lilly and Boehringer launch Lantus biosimilar in UK Lantus is also being squeezed by Novo Nordisk's rival basal insulin Levemir (insulin detemir) which has been growing strongly with sales approaching $2.5bn last year, while Merck &Co and

Sanofi keeps Toujeo price level with Lantus in UK

Sanofi keeps Toujeo price level with Lantus in UK ward off the threat of biosimilars - which have started to appear in Eastern Europe - as well as Novo Nordisk's Levemir (insulin detemir) which has been growing strongly with sales approaching

Hanover wins Novo Nordisk public affairs and policy account

Hanover wins Novo Nordisk public affairs and policy account Novo has built its business on a range of diabetes, led by currently the insulins Levemir, NovoRapid and Tresiba and the GLP-1 agonist Victoza (liraglutide).

[ Previous 5 results ] 1 2 3 4 5 6 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

The other side of … rheumatoid arthritis
For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
How to lessen site burden with a targeted patient recruitment strategy
Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...
Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...

Infographics